Works matching AU Dae Ho Lee

Results: 149
    1
    2
    3

    Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR.

    Published in:
    2015
    By:
    • Yoon Ji Choi;
    • Dae Ho Lee;
    • Chang Min Choi;
    • Jung Shin Lee;
    • Seung Jin Lee;
    • Jin-Hee Ahn;
    • Sang-We Kim;
    • Choi, Yoon Ji;
    • Lee, Dae Ho;
    • Choi, Chang Min;
    • Lee, Jung Shin;
    • Lee, Seung Jin;
    • Ahn, Jin-Hee;
    • Kim, Sang-We
    Publication type:
    journal article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

    Published in:
    Nature Genetics, 2012, v. 44, n. 8, p. 852, doi. 10.1038/ng.2330
    By:
    • Zhang, Zhenfeng;
    • Lee, Jae Cheol;
    • Lin, Luping;
    • Olivas, Victor;
    • Au, Valerie;
    • LaFramboise, Thomas;
    • Abdel-Rahman, Mohamed;
    • Wang, Xiaoqi;
    • Levine, Alan D;
    • Rho, Jin Kyung;
    • Choi, Yun Jung;
    • Choi, Chang-Min;
    • Kim, Sang-We;
    • Jang, Se Jin;
    • Park, Young Soo;
    • Kim, Woo Sung;
    • Lee, Dae Ho;
    • Lee, Jung-Shin;
    • Miller, Vincent A;
    • Arcila, Maria
    Publication type:
    Article
    18
    19

    Clinical outcomes and prognostic factors inpatients with breast diffuse large B cell lymphoma;Consortium for Improving Survival of Lymphoma(CISL) study.

    Published in:
    BMC Cancer, 2010, v. 10, p. 321, doi. 10.1186/1471-2407-10-321
    By:
    • Ho-Young Yhim;
    • Hye Jin Kang;
    • Yoon Hee Choi;
    • Seok Jin Kim;
    • Won Seog Kim;
    • Yee Soo Chae;
    • Jin Seok Kim;
    • Chul Won Choi;
    • Sung Yong Oh;
    • Hyeon Seok Eom;
    • Jeong-A Kim;
    • Jae Hoon Lee;
    • Jong-Ho Won;
    • Hyeok Shim;
    • Je-Jung Lee;
    • Hwa Jung Sung;
    • Hyo Jung Kim;
    • Dae Ho Lee;
    • Cheolwon Suh;
    • Jae-Yong Kwak
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    28

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    29
    30

    Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge.

    Published in:
    2019
    By:
    • Choi, In Suck;
    • Park, Ie Byung;
    • Lee, Kiyoung;
    • Ahn, Tae Hoon;
    • Kim, Ju Han;
    • Ahn, Youngkeun;
    • Chae, Sung-Chull;
    • Kim, Hyo-Soo;
    • Kim, Young Jo;
    • Cho, Myeong Chan;
    • Kim, Chong Jin;
    • Jeong, Myung Ho;
    • Lee, Dae Ho;
    • Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) investigators
    Publication type:
    journal article
    31
    32
    33
    34
    35

    Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01).

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 24, p. 6234, doi. 10.1002/cncr.27630
    By:
    • Sun, Jong-Mu;
    • Lee, Ki Hyeong;
    • Kim, Sang-we;
    • Lee, Dae Ho;
    • Min, Young Joo;
    • Yun, Hwan Jung;
    • Kim, Hoon Kyo;
    • Song, Hong Suk;
    • Kim, Yeul Hong;
    • Kim, Bong-Seog;
    • Hwang, In Gyu;
    • Lee, Keehyun;
    • Jo, Sook Jung;
    • Lee, Jae Won;
    • Ahn, Jin Seok;
    • Park, Keunchil;
    • Ahn, Myung-Ju
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.

    Published in:
    Cancer Science, 2010, v. 101, n. 11, p. 2443, doi. 10.1111/j.1349-7006.2010.01698.x
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Kim, Seok Jin;
    • Lee, Suee;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Chae, Yee Soo;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Lee, Ho Sup;
    • Lee, Gyeong-Won;
    • Eom, Hyeon Seok
    Publication type:
    Article
    46
    47
    48
    49
    50